Addiction rehab monitoring assay

Answers from the Lab

Mayo Clinic Laboratories now offers a comprehensive addiction rehabilitation monitoring profile, an innovative assay that employs a combination of technologies to test urine for the most commonly used substances. In this test specific episode of the "Answers From the Lab" podcast, Loralie Langman, Ph.D., and Paul Jannetto, Ph.D., discuss the test’s utility to help guide and monitor treatment.

“Urine drug testing has been referred to as the technology of addiction treatment,” Dr. Jannetto says. “It’s not meant to be punitive, but rather as a tool to support recovery and provide motivation or reinforcement for abstinence.”

Developed for clinicians who manage complex patients struggling with substance use disorders to common substances such as opioids, marijuana, alcohol, and nicotine, the addiction monitoring profile offers improved specificity and includes adulterant testing and enhanced reports. Listen to learn more about how our testing enables accurate answers and simplified results to clarify patients’ substance use.

Note: Podcasts will not playback on Internet Explorer. Please use an alternative web browser, or listen from your mobile device on a preferred listening app.


Useful information

  • Assessing patients at-risk for substance use disorders.
  • Detecting drug use involving stimulants, barbiturates, benzodiazepines, cocaine, opioids, tetrahydrocannabinol, alcohol, and nicotine.
  • This test is not intended for use in employment-related testing.

Specimen requirements

Specimen Type: Urine Container, 60 mL (T313)

Specimen Volume: 30 mL

Container/Tube: Plastic urine container

Collection Instructions:

  • Collect a random urine specimen.
  • Submit 30 mL in 1 plastic bottle.
  • No preservative.

Additional Information:

  • No specimen substitutions.
  • Submitting less than 30 mL may compromise the ability to perform all necessary testing.
  • STATS are not accepted for this procedure.

Performance information

Analytic time: 2 to 5 days 

Days performed: Varies

The latest

Barbara J. Toman

Barbara J. Toman is a Senior Communications Specialist at Mayo Clinic Laboratories. She is also the science writer for Mayo’s Neurosciences Update newsletter, which helps referring physicians to stay informed about Mayo’s treatment and research. Barbara has worked at Mayo Clinic since 2007. She enjoys international travel and cooking.